Smith & Nephew
  • Print
  • Close

ACTICAOT◊ 7 (with SILCRYST(TM) Nanocrystals) in the management of a venous leg ulcer

Introduction
This case study demonstrates the use of ACTICOAT◊ 7 in the management of a venous leg ulcer in a patient with diabetes.

Patient
The patient was a 71 year old male, treated at home for an ulcer located on the lower medial aspect of the leg. The ulcer had been present for two months. The ulcer had been previously dressed with a hydrocolloid dressing. At the beginning of treatment the wound measured 5cm x 9cm x 2mm. The wound was covered with 95% non-viable tissue and the surrounding skin was reddened and macerated. Exudate levels were small and no clinical signs of infection were detected (Fig.1).

Treatment
The wound was cleansed and moistened ACTICOAT◊ 7 was then applied. The ACTICOAT◊ 7 was covered with moistened gauzes and dry gauzes on the top. Dressing changes were carried out every 7 days (Fig.2). Due to the diabetes and possibly an ischaemic component, compression therapy was not used.

Outcome
After two weeks the wound was completely free of non-viable tissue. After 4 weeks the wound was completely closed (Fig.3).

acticoat 7 case studies venus leg ulcer acticoat 7 case studies venus leg ulcer2 acticoat 7 case studies venus leg ulcer3
Fig 1 Fig 2 Fig 3

Introduction
This case study illustrates the use of ACTICOAT◊ 7 in the management of a diabetic foot ulcer.

™SILCRYST is a trademark of NUCRYST Pharmaceuticals Corp, used under license.

  • Copyright © 2009 Smith & Nephew